LSPedia Receives Strategic Growth Investment from Bregal Sagemount

The company plans to use the funding to continue developing new products, expand its customer base, and support its global growth strategy.

LSPedia helps pharmaceutical companies, distributors, healthcare systems, dispensers, and government agencies track and verify serialized products across complex supply chains.

Its cloud-based platform was designed to support serialization and global track-and-trace regulations, including the Drug Supply Chain Security Act (DSCSA), FMD, and other requirements across 40 countries. The platform helps customers manage compliance, improve supply chain visibility, and simplify key operational workflows through one integrated system.

Today, LSPedia supports more than 1,600 customers and processes over 900 million serialized units each year through a network of more than 750,000 trading partner connections. The company’s large network and transaction volume have made it an important technology and workflow platform for global supply chains, helping partners manage both compliance and daily operations.

As part of its next growth phase, LSPedia is expanding its platform to help customers collect, connect, and use serialized product data more quickly and efficiently across supply chain networks.

The company’s main solution, OneScan, uses a scan-once process that captures serialized product information and automatically sends the data to the correct workflow. This helps reduce manual work and improve real-time supply chain visibility. Combined with AI-powered insights, LSPedia helps customers go beyond basic compliance by providing better visibility and smarter decision-making across operations.

Zuhair Khan, Partner and Co-Head of Basecamp at Sagemount, added: "LSPedia has built a uniquely comprehensive platform that serves participants across the entire pharmaceutical supply chain. The Company’s focus on helping customers meet regulatory requirements while also providing operational value creates a compelling foundation for long-term growth. We are excited to partner with Riya and the team as they accelerate innovation, including advanced traceability and analytics, to support customers worldwide."

Read More:Stord Raises $250M Series F Funding, at $3B Valuation

"We built LSPedia from the ground up, bootstrapped with a focus on the operational realities of pharmaceutical compliance," said Riya Cao, Founder and CEO of LSPedia. "Together with Sagemount, we see a significant opportunity to continue expanding the platform, deepening customer relationships, and investing in the next generation of supply chain connectivity and intelligence. With innovations like OneScan and Traceability AI, we’re helping customers achieve supply chain visibility, integration, and predictive insights with the speed and scale today’s environment demands."

About LSPedia

Founded in 2013 by Riya Cao, LSPedia provides compliance and SaaS solutions for the pharmaceutical industry and other sectors. Its OneScan platform helps manufacturers, distributors, healthcare providers, and supply chain partners track, verify and manage serialized products throughout the supply chain. As one of the largest processors of serialized data in the industry, LSPedia focuses on workflow automation, operational efficiency and data security.

Read More:CasaPerks Technologies Raises $15.8M in Seed Funding